Clinical Trial Update: A Study of Buntanetap in Participants With PD [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Buntanetap in Parkinson's disease, including patients with deep brain stimulation; the study is in Phase 2/3 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Buntanetap

Snippet

Sponsor: Annovis Bio Inc. | Conditions: Parkinson's Disease (PD), Deep Brain Stimulation | Phase 2, Phase 3 | Status: RECRUITING